Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome

American Journal of Pathology

Volumn 177, Issue 2, 2010, Pages 766-776

  Stevenson, Heather L ^a   Estes, Mark D ^a,b,c   Thirumalapura, Nagaraja R ^a   Walker, David H ^a,b,c   Ismail, Nahed ^d  

^a Department of Pathology ^*  (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c Center for Biodefense and Emerging Infectious Diseases   (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; DOXYCYCLINE; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE ASSOCIATION; EHRLICHIA CHAFFEENSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN MONOCYTIC EHRLICHIOSIS; INFLAMMATION; LIVER INJURY; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; TISSUE INJURY; TOXIC SHOCK SYNDROME; WILD TYPE;

EID: 77957264827     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091110     Document Type: Article

References (52)

1. Olano JP, Walker DH: Human ehrlichioses. Med Clin North Am 2002, 86:375-392
2. Walker DH, Dumler JS: Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med 1997, 121:785-791
3. Fichtenbaum CJ, Peterson LR, Weil GJ: Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am J Med 1993, 95:351-357
4. +Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. J Immunol 2004, 172:1786-1800
5. Ismail N, Stevenson HL, Walker DH: Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection. Infect Immun 2006, 74:1846-1856
6. Sehdev AE, Dumler JS: Hepatic pathology in human monocytic ehrlichiosis. Ehrlichia chaffeensis infection. Am J Clin Pathol 2003, 119:859-865
7. Walker DH: Emerging human ehrlichioses: recently recognized, widely distributed, life-threatening tick-borne diseases. Emerging infections I. Edited by WM Scheld, D Armstrong, and JM Hughes. Washington, AMS Press, 1998, pp. 81-91
8. Shibata S, Kawahara M, Rikihisa Y, Fujita H, Watanabe Y, Suto C, Ito T: New Ehrlichia species closely related to Ehrlichia chaffeensis isolated from Ixodes ovatus ticks in Japan. J Clin Microbiol 2000, 38:1331-1338
9. Stevenson HL, Jordan JM, Peerwani Z, Wang HQ, Walker DH, Ismail N: An intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infection. Infect Immun 2006, 74:4856-4864
10. Bitsaktsis C, Huntington J, Winslow GM: Production of IFN-γ by CD4 T cells is essential for resolving ehrlichia infection. J Immunol 2004, 172:6894-6901
11. Bitsaktsis C, Winslow G: Fatal recall responses mediated by CD8 T cells during intracellular bacterial challenge infection. J Immunol 2006, 177:4644-4651
12. Ismail N, Crossley EC, Stevenson HL, Walker DH: Relative importance of T cell subsets in monocytotropic ehrlichiosis: A novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis. Infect Immun 2007, 75:4608-4620
13. Stevenson HL, Crossley EC, Thirumalapura N, Walker DH, Ismail N: Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis. Infect Immun 2008, 76:1434-1444
14. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, III, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A: Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529
15. Tsutsui H, Adachi K, Seki E, Nakanishi K: Cytokine-induced inflammatory liver injuries. Curr Mol Med 2003, 3:545-559
16. Bancroft GJ: The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993, 5:503-510
17. Berg RE, Crossley E, Murray S, Forman J: Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes. J Immunol 2005, 175:1751-1757
18. Barry M, Bleackley RC: Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2002, 2:401-409
19. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001, 12:53-72
20. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91
21. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002, 2:735-747
22. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993, 90:3725-3729
23. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER: Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma J Immunol 1994, 152:1883-1887
24. Wald O, Weiss ID, Wald H, Shoham H, Bar-Shavit Y, Beider K, Galun E, Weiss L, Flaishon L, Shachar I, Nagler A, Lu B, Gerard C, Gao JL, Mishani E, Farber J, Peled A: IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 2006, 176:4716-4729
25. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, Das A, Lopes AR, Borrow P, Williams K, Humphreys E, Afford S, Adams DH, Bertoletti A, Maini MK: Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007, 204:667-680
26. Liu ZX, Govindarajan S, Okamoto S, Dennert G: NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 2000, 164:6480-6486
27. Inayoshi M, Naitou H, Kawamori F, Masuzawa T, Ohashi N: Characterization of Ehrlichia species from Ixodes ovatus ticks at the foot of Mt. Fuji, Japan. Microbiol Immunol 2004, 48:737-745
28. Sotomayor E, Popov V, Feng H-M, Walker DH, Olano JP: Animal model of fatal human monocytotropic ehrlichiosis. Am J Pathol 2001, 158:757-769
29. Morsy MA, Norman PJ, Mitry R, Rela M, Heaton ND, Vaughan RW: Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique. Lab Invest 2005, 85:285-296
30. Ortaldo JR, Sharrow SO, Timonen T, and Herberman RB: Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol 1981, 127:2401-2409
31. Belperio JA, Keane MP, Burdick MD, Lynch JP, III, Xue YY, Li K, Ross DJ, Strieter RM: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002, 169:1037-1049
32. Parker GA, Picut CA: Liver immunobiology. Toxicol Pathol 2005, 33:52-62
33. El-Masry S, Lotfy M, Nasif WA, El-Kady IM, Al-Badrawy M: Elevated serum level of interleukin (IL)-18, interferon (IFN)-gamma and soluble Fas in patients with pulmonary complications in tuberculosis. Acta Microbiol Immunol Hung 2007, 54:65-77
34. Kawakami K, Kinjo Y, Uezu K, Miyagi K, Kinjo T, Yara S, Koguchi Y, Miyazato A, Shibuya K, Iwakura Y, Takeda K, Akira S, Saito A: Interferon-gamma production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18. Microbes Infect 2004, 6:339-349
35. French AR, Holroyd EB, Yang L, Kim S, Yokoyama WM: IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation. Cytokine 2006, 35:229-234
36. Inngjerdingen M, Damaj B, Maghazachi AA: Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001, 97:367-375
37. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B: Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol 1996, 156:322-327
38. de Sousa R, Ismail N, Nobrega SD, Franca A, Amaro M, Anes M, Pocas J, Coelho R, Torgal J, Bacellar F, Walker DH: Intralesional expression of mRNA of interferon- gamma, tumor necrosis factor-alpha, interleukin-10, nitric oxide synthase, indoleamine-2,3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis. J Infect Dis 2007, 196:770-781
39. Bitsaktsis C, Nandi B, Racine R, Macnamara KC, Winslow G: T cell-independent humoral immunity is sufficient for protection against fatal intracellular Ehrlichia infection. Infect Immun 2007, 75:4933-4941
40. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK: Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009, 183:5301-5310
41. Xu L, Yoon H, Zhao MQ, Liu J, Ramana CV, Enelow RI: Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol 2004, 173:721-725
42. Etogo AO, Nunez J, Lin CY, Toliver-Kinsky TE, Sherwood ER: NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis. J Immunol 2008, 180:6334-6345
43. Klein MB, Hu S, Chao CC, Goodman JL: The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J Infect Dis 2000, 182:200-205
44. Miura K, Rikihisa Y: Liver transcriptome profiles associated with strain-specific Ehrlichia chaffeensis-induced hepatitis in SCID mice. Infect Immun 2009, 77:245-254
45. Anders HJ, Frink M, Linde Y, Banas B, Wornle M, Cohen CD, Vielhauer V, Nelson PJ, Grone HJ, Schlondorff D: CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 2003, 170:5658-5666
46. Golden-Mason L, Kelly AM, Doherty DG, Traynor O, McEntee G, Kelly J, Hegarty JE, O'Farrelly C: Hepatic interleuklin 15 (IL-15) expression: implications for local NK/NKT cell homeostasis and development. Clin Exp Immunol 2004, 138:94-101
47. Bekiaris V, Timoshenko O, Hou TZ, Toellner K, Shakib S, Gaspal F, McConnell FM, Parnell SM, Withers D, Buckley CD, Sweet C, Yokoyama WM, Anderson G, Lane PJ: Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection. J Immunol 2008, 180:6768-6776
48. Degli-Esposti MA, Smyth MJ: Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005, 5:112-124
49. Kalinski P, Moser M: Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses. Nat Rev Immunol 2005, 5:251-260
50. Kang SJ, Liang HE, Reizis B, Locksley RM: Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells. Immunity 2008, 29:819-833
51. Moretta L, Ferlazzo G, Bottino C, Vitale M, Pende D, Mingari MC, Moretta A: Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006, 214:219-228
52. Newman KC, Riley EM: Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007, 7:279-291